Exact Sciences posted $102.9 million in second quarter 2018 revenue, missing investor predictions by $1.8 million, or 1.7 percent, causing its stock to fall 18.75 percent.
Exact Sciences is sponsoring Fight Colorectal Cancer and PGA Tour professional Tom Lehman to promote Fight CRC.
RedHill Biopharma’s Crohn’s disease drug, RHB-104, successfully met its primary and secondary endpoints, achieving remission at 26 weeks.
More articles on gastroenterology:
Actor Matthew Perry undergoes tracheostomy in Los Angeles hospital — 5 insights
ASGE recognizes Metropolitan Gastroenterology Consultants — 3 insights
Dr. William Karnes: Key trends and challenges in GI today
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.